START FREE TRIAL

Did AES Just Become Private Equity’s AI Power Bet?

If you blinked this week, you might have missed it. AES Corp. (NYSE:AES) is reportedly in advanced talks to be acquired by BlackRock Inc.’s...

Lululemon’s Proxy Battle Looks Tactical, But It’s STRATEGIC

The battle inside Lululemon (NASDAQ:LULU) just escalated. Founder Chip...

Did AES Just Become Private Equity’s AI Power Bet?

If you blinked this week, you might have missed...

Block’s MASSIVE Layoffs — Is This An AI Shift Or Margin Mirage?

Block (NYSE:SQ) just made one of the boldest moves...

Did Papa John’s Just Signal RETREAT, Not A REAL Turnaround?

When Papa John’s International (NASDAQ:PZZA) announced it would close...

Did Paramount OUTPLAY Netflix — Or Did Netflix Win?

When Netflix (NASDAQ:NFLX) decided not to match Paramount Skydance’s...

Is Merck’s HIV Win Really About Keytruda?

When Merck & Co. (NYSE:MRK) reported Phase 3 data...

Technology & AI

Consumer & Retail

Healthcare

Recent Posts

Lululemon’s Proxy Battle Looks Tactical, But It’s STRATEGIC

The battle inside Lululemon (NASDAQ:LULU) just escalated. Founder Chip Wilson has moved from quiet frustration to open confrontation, accusing...

Did AES Just Become Private Equity’s AI Power Bet?

If you blinked this week, you might have missed it. AES Corp. (NYSE:AES) is reportedly in advanced talks to...

Block’s MASSIVE Layoffs — Is This An AI Shift Or Margin Mirage?

Block (NYSE:SQ) just made one of the boldest moves in corporate America this year. CEO Jack Dorsey announced the...

Did Papa John’s Just Signal RETREAT, Not A REAL Turnaround?

When Papa John’s International (NASDAQ:PZZA) announced it would close 300 U.S. stores by 2027, slash menu items, and cut...

Did Paramount OUTPLAY Netflix — Or Did Netflix Win?

When Netflix (NASDAQ:NFLX) decided not to match Paramount Skydance’s $31-per-share offer for Warner Bros. Discovery, it wasn’t waving a...

Is Merck’s HIV Win Really About Keytruda?

When Merck & Co. (NYSE:MRK) reported Phase 3 data showing its two-drug HIV regimen of doravirine and islatravir matched...

Meta & AMD’s $100B Deal Isn’t Supply — It’s Strategic SHIFT!

When Meta Platforms (NASDAQ:META) announced it would buy 6 gigawatts of AI computing power from AMD in a deal...

Did Novo Nordisk’s Trial Miss Just Hand Lilly The Edge?

It has been a bruising few weeks for Novo Nordisk (NYSE:NVO). First came the clinical disappointment: CagriSema, the company’s...

PayPal Just Popped On Deal Talk — But The REAL Story Is The Reset

PayPal (NASDAQ:PYPL) ripped higher on Feb. 23, 2026, after Bloomberg reported early-stage takeover interest from potential suitors. The move...

Is Apple’s Chip Strategy About Security — Or About Tariff Exposure?

Apple (NASDAQ:AAPL) is quietly doing something big in the desert. It is using its wallet to pull more of...

Is Chevron’s Iraq Deal A Win — Or A Twelve-Month Test With Hidden Friction?

Chevron (NYSE:CVX) just slid into the driver’s seat for one of Iraq’s crown-jewel oil assets. The company signed preliminary...

Nvidia’s Earnings May Beat Again—Why The Stock Still Might Not Care!

Nvidia reports earnings this week with expectations still firmly elevated. Consensus continues to model strong revenue growth, healthy profitability,...

Popular

spot_img